DR.AGAR.EYE | INDO-GLOBAL ENT. | DR.AGAR.EYE/ INDO-GLOBAL ENT. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 35.8 | -31.9 | - | View Chart |
P/BV | x | 14.6 | 1.4 | 1,014.5% | View Chart |
Dividend Yield | % | 0.1 | 0.0 | - |
DR.AGAR.EYE INDO-GLOBAL ENT. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DR.AGAR.EYE Mar-23 |
INDO-GLOBAL ENT. Mar-20 |
DR.AGAR.EYE/ INDO-GLOBAL ENT. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,580 | 20 | 7,745.1% | |
Low | Rs | 545 | 20 | 2,671.6% | |
Sales per share (Unadj.) | Rs | 570.0 | 0 | - | |
Earnings per share (Unadj.) | Rs | 78.6 | -0.7 | -11,999.6% | |
Cash flow per share (Unadj.) | Rs | 121.5 | -0.7 | -18,558.4% | |
Dividends per share (Unadj.) | Rs | 3.00 | 0 | - | |
Avg Dividend yield | % | 0.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 241.1 | 11.1 | 2,173.0% | |
Shares outstanding (eoy) | m | 4.70 | 6.37 | 73.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.9 | 0 | - | |
Avg P/E ratio | x | 13.5 | -31.1 | -43.5% | |
P/CF ratio (eoy) | x | 8.7 | -31.1 | -28.1% | |
Price / Book Value ratio | x | 4.4 | 1.8 | 239.7% | |
Dividend payout | % | 3.8 | 0 | - | |
Avg Mkt Cap | Rs m | 4,994 | 130 | 3,842.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 533 | 1 | 106,520.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 2,679 | 0 | - | |
Other income | Rs m | 21 | 0 | - | |
Total revenues | Rs m | 2,699 | 0 | - | |
Gross profit | Rs m | 756 | -1 | -51,760.3% | |
Depreciation | Rs m | 202 | 0 | - | |
Interest | Rs m | 80 | 1 | 11,652.2% | |
Profit before tax | Rs m | 494 | -2 | -22,870.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 125 | 2 | 6,178.2% | |
Profit after tax | Rs m | 369 | -4 | -8,853.7% | |
Gross profit margin | % | 28.2 | 0 | - | |
Effective tax rate | % | 25.3 | -93.4 | -27.0% | |
Net profit margin | % | 13.8 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 465 | 0 | 1,163,500.0% | |
Current liabilities | Rs m | 964 | 7 | 14,011.6% | |
Net working cap to sales | % | -18.6 | 0 | - | |
Current ratio | x | 0.5 | 0 | 8,303.8% | |
Inventory Days | Days | 71 | 0 | - | |
Debtors Days | Days | 1 | 0 | - | |
Net fixed assets | Rs m | 3,750 | 80 | 4,692.9% | |
Share capital | Rs m | 47 | 64 | 73.8% | |
"Free" reserves | Rs m | 1,086 | 7 | 15,542.2% | |
Net worth | Rs m | 1,133 | 71 | 1,603.3% | |
Long term debt | Rs m | 358 | 2 | 14,966.5% | |
Total assets | Rs m | 4,216 | 80 | 5,272.0% | |
Interest coverage | x | 7.1 | -2.1 | -337.6% | |
Debt to equity ratio | x | 0.3 | 0 | 933.5% | |
Sales to assets ratio | x | 0.6 | 0 | - | |
Return on assets | % | 10.7 | -4.4 | -245.0% | |
Return on equity | % | 32.6 | -5.9 | -551.6% | |
Return on capital | % | 38.5 | -2.0 | -1,923.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 9 | 0 | - | |
Net fx | Rs m | -9 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 696 | -1 | -50,817.5% | |
From Investments | Rs m | -706 | NA | - | |
From Financial Activity | Rs m | 3 | 1 | 189.8% | |
Net Cashflow | Rs m | -7 | 0 | - |
Indian Promoters | % | 71.9 | 2.8 | 2,549.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.6 | 0.0 | - | |
FIIs | % | 0.6 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.1 | 97.2 | 28.9% | |
Shareholders | 3,572 | 543 | 657.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare DR.AGAR.EYE With: APOLLO HOSPITALS DR. LAL PATHLABS KIMS METROPOLIS HEALTHCARE NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | DR.AGAR.EYE | INDO-GLOBAL ENT. |
---|---|---|
1-Day | 0.84% | -4.76% |
1-Month | 8.01% | 6.24% |
1-Year | 186.93% | -13.28% |
3-Year CAGR | 112.15% | -7.78% |
5-Year CAGR | 58.74% | -4.74% |
* Compound Annual Growth Rate
Here are more details on the DR.AGAR.EYE share price and the INDO-GLOBAL ENT. share price.
Moving on to shareholding structures...
The promoters of DR.AGAR.EYE hold a 71.9% stake in the company. In case of INDO-GLOBAL ENT. the stake stands at 2.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DR.AGAR.EYE and the shareholding pattern of INDO-GLOBAL ENT..
Finally, a word on dividends...
In the most recent financial year, DR.AGAR.EYE paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 3.8%.
INDO-GLOBAL ENT. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of DR.AGAR.EYE, and the dividend history of INDO-GLOBAL ENT..
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.